Published in J Clin Microbiol on June 01, 1996
Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care (2008) 1.49
Critical evaluation of 4-week incubation for fungal cultures: is the fourth week useful? J Clin Microbiol (1998) 1.14
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility. Eur J Clin Microbiol Infect Dis (2011) 0.98
Performance of fungal blood cultures by using the Isolator collection system: is it cost-effective? J Clin Microbiol (1996) 0.96
Development of a nested PCR for detection of Cryptococcus neoformans in cerebrospinal fluid. J Clin Microbiol (1998) 0.95
Immunoglobulin G responses to a panel of Candida albicans antigens as accurate and early markers for the presence of systemic candidiasis. J Clin Microbiol (2008) 0.91
Comparison of five days versus seven days of incubation for detection of positive blood cultures by the Bactec 9240 system. Eur J Clin Microbiol Infect Dis (1998) 0.86
Detection of Candida albicans by mass spectrometric fingerprinting. Curr Microbiol (2011) 0.79
Dielectrophoresis for Biomedical Sciences Applications: A Review. Sensors (Basel) (2017) 0.75
Clinical benefit of recovering dermatophytes from skin swabs sent for bacterial culture. J Clin Microbiol (2004) 0.75
Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis. PLoS One (2017) 0.75
Use of Raman spectroscopy to decrease time for identifying the species of Candida growth in cultures. Avicenna J Med Biotechnol (2015) 0.75
Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med (1979) 12.90
The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis (1983) 10.03
The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis (1997) 9.39
Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. J Clin Microbiol (1981) 8.49
Campylobacter enteritis. N Engl J Med (1981) 7.98
Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis (1974) 7.65
Controlled evaluation of the volume of blood cultured in detection of bacteremia and fungemia. J Clin Microbiol (1982) 6.19
Controlled comparison of the BacT/Alert and BACTEC 660/730 nonradiometric blood culture systems. J Clin Microbiol (1992) 5.09
Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries. Lancet (1999) 4.64
The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis (1983) 4.52
Practice guidelines for the management of infectious diarrhea. Clin Infect Dis (2001) 4.49
BacT/Alert: an automated colorimetric microbial detection system. J Clin Microbiol (1990) 4.35
Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests. J Infect Dis (1977) 4.00
Controlled evaluation of BacT/Alert standard aerobic and FAN aerobic blood culture bottles for detection of bacteremia and fungemia. J Clin Microbiol (1995) 3.51
Evaluation of cefazolin, a new cephalosporin antibiotic. Antimicrob Agents Chemother (1973) 3.44
Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent. J Infect Dis (1977) 3.15
Isolation of Campylobacter fetus subsp. jejuni from migratory waterfowl. J Clin Microbiol (1980) 3.11
Fatal Mycobacterium tuberculosis bloodstream infections in febrile hospitalized adults in Dar es Salaam, Tanzania. Clin Infect Dis (1998) 2.81
Comparison of acridine orange and Gram stains for detection of microorganisms in cerebrospinal fluid and other clinical specimens. J Clin Microbiol (1981) 2.77
Development of a standardized screening method for detection of vancomycin-resistant enterococci. J Clin Microbiol (1994) 2.77
Controlled evaluation of BACTEC Plus 26 and Roche Septi-Chek aerobic blood culture bottles. J Clin Microbiol (1991) 2.62
Controlled clinical laboratory comparison of BACTEC plus aerobic/F resin medium with BacT/Alert aerobic FAN medium for detection of bacteremia and fungemia. J Clin Microbiol (1997) 2.54
Controlled comparison of the BACTEC high-blood-volume fungal medium, BACTEC Plus 26 aerobic blood culture bottle, and 10-milliliter isolator blood culture system for detection of fungemia and bacteremia. J Clin Microbiol (1993) 2.49
Bactericidal antibody after colonization with Neisseria meningitidis. J Infect Dis (1973) 2.35
Controlled evaluation of 5 versus 10 milliliters of blood cultured in aerobic BacT/Alert blood culture bottles. J Clin Microbiol (1994) 2.32
Comparison of acridine orange, methylene blue, and Gram stains for blood cultures. J Clin Microbiol (1982) 2.30
A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy. J Infect Dis (2000) 2.29
Effect of agitation and terminal subcultures on yield and speed of detection of the Oxoid Signal blood culture system versus the BACTEC radiometric system. J Clin Microbiol (1989) 2.25
Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates. J Antimicrob Chemother (1982) 2.25
Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia. J Clin Microbiol (2001) 2.23
Controlled evaluation of BacT/alert standard anaerobic and FAN anaerobic blood culture bottles for the detection of bacteremia and fungemia. J Clin Microbiol (1995) 2.21
Clinical microbiology in developing countries. Emerg Infect Dis (2001) 2.18
Clinical impact of bacteria and fungi recovered only from broth cultures. J Clin Microbiol (1995) 2.17
Diagnostic utility of postmortem blood cultures. Arch Pathol Lab Med (1993) 2.06
Evaluation of transport and storage techniques for isolation of Campylobacter fetus subsp. jejuni from turkey cecal specimens. J Clin Microbiol (1981) 2.06
Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. Antimicrob Agents Chemother (1981) 2.04
Application of rejection criteria for stool ovum and parasite examinations. J Clin Microbiol (1992) 2.04
Evaluation of preservative fluid for urine collected for culture. J Clin Microbiol (1979) 2.03
Controlled evaluation of the agar-slide and radiometric blood culture systems for the detection of bacteremia and fungemia. J Clin Microbiol (1986) 1.98
Use of a sodium polyanetholesulfonate disk for the identification of Gardnerella vaginalis. J Clin Microbiol (1985) 1.97
Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology (1997) 1.95
Reliability of cord formation in BACTEC media for presumptive identification of mycobacteria. J Clin Microbiol (1993) 1.94
Controlled evaluation of BACTEC PLUS 27 and Roche Septi-Chek anaerobic blood culture bottles. J Clin Microbiol (1992) 1.92
Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J Med (1985) 1.92
Rejection criteria for endotracheal aspirates from adults. J Clin Microbiol (1993) 1.91
Recovery of clinically important microorganisms from the BacT/Alert blood culture system does not require testing for seven days. Diagn Microbiol Infect Dis (1993) 1.83
Controlled comparison of original vented aerobic fan medium with new nonvented BacT/ALERT FA medium for culturing blood. J Clin Microbiol (2001) 1.81
Controlled evaluation of the effect of atmosphere of incubation on detection of bacteremia and fungemia in supplemented peptone broth. J Clin Microbiol (1982) 1.81
Prevalence of congenital or acquired complement deficiency in patients with sporadic meningocococcal disease. N Engl J Med (1983) 1.79
Rationale for selective use of anaerobic blood cultures. J Clin Microbiol (1993) 1.77
Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration. J Infect Dis (1982) 1.74
Enriched brucella medium for storage and transport of cultures of Campylobacter fetus subsp. jejuni. J Clin Microbiol (1980) 1.73
Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: proof provided by typing with a DNA probe. J Infect Dis (1988) 1.72
Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis. Lancet (1982) 1.68
Clinical importance of identifying coagulase-negative staphylococci isolated from blood cultures: evaluation of MicroScan Rapid and Dried Overnight Gram-Positive panels versus a conventional reference method. J Clin Microbiol (1998) 1.68
Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1984) 1.67
Cryptosporidium, enterocytozoon, and cyclospora infections in pediatric and adult patients with diarrhea in Tanzania. Clin Infect Dis (1999) 1.64
Bacterial endocarditis caused by Oerskovia turbata. Ann Intern Med (1975) 1.61
Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures. J Clin Microbiol (2005) 1.60
Fever and human immunodeficiency virus infection as sentinels for emerging mycobacterial and fungal bloodstream infections in hospitalized patients >/=15 years old, Bangkok. J Infect Dis (1999) 1.60
Controlled evaluation of supplemented peptone and Bactec blood culture broths for the detection of bacteremia and fungemia. J Clin Microbiol (1985) 1.58
Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective. Antimicrob Agents Chemother (2001) 1.58
Features of benign granular cell tumor on fine needle aspiration. Acta Cytol (1999) 1.57
Seasonal variation in the etiology of bloodstream infections in a febrile inpatient population in a developing country. Int J Infect Dis (2001) 1.56
Comparative evaluation of Oxoid Signal and BACTEC radiometric blood culture systems for the detection of bacteremia and fungemia. J Clin Microbiol (1988) 1.55
Comparison of direct and standard antimicrobial disk susceptibility testing for bacteria isolated from blood. J Clin Microbiol (1979) 1.54
Gardnerella vaginalis bacteremia: a review of thirty cases. Obstet Gynecol (1984) 1.53
Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology (1998) 1.50
Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation (1999) 1.49
Lionfish envenomation. Ann Emerg Med (1996) 1.48
Relevance of the number of positive bottles in determining clinical significance of coagulase-negative staphylococci in blood cultures. J Clin Microbiol (2001) 1.45
Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. Res Microbiol (1989) 1.43
Zinc alpha-2-glycoprotein is expressed by malignant prostatic epithelium and may serve as a potential serum marker for prostate cancer. Clin Cancer Res (2001) 1.43
Neisseria gonorrhoeae strains inhibited by vancomycin in selective media and correlation with auxotype. J Clin Microbiol (1981) 1.42
Automated blood culture systems. Clin Lab Med (1994) 1.40
Shigellosis in custodial institutions. Am J Epidemiol (1970) 1.40
Epidemic Shiga bacillus dysentery in Central America. II. Epidemiologic studies in 1969. J Infect Dis (1970) 1.39
Rapid bacterial antigen detection is not clinically useful. J Clin Microbiol (1995) 1.39
Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates. Antimicrob Agents Chemother (1980) 1.39
Clinical importance of increased sensitivity of BacT/Alert FAN aerobic and anaerobic blood culture bottles. J Clin Microbiol (1996) 1.39
Controlled evaluation of Trypticase soy broth in agar slide and conventional blood culture systems. J Clin Microbiol (1985) 1.35
A clinical trial of oral therapy in a rural cholera-treatment center. Am J Trop Med Hyg (1970) 1.34
Clinical comparison of an agar slide blood culture bottle with tryptic soy broth and a conventional blood culture bottle with supplemented peptone broth. J Clin Microbiol (1985) 1.33
Cryptosporidium species, a protean protozoan. J Clin Microbiol (1987) 1.31
Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation (2001) 1.30
Controlled evaluation of blood culture medium containing gelatin and V-factor-analog for detection of septicemia in children. J Clin Microbiol (1988) 1.28
Effect of atmosphere and duration of incubation on primary isolation of group A streptococci from throat cultures. J Clin Microbiol (1983) 1.27
Motility-indole-lysine medium for presumptive identification of enteric pathogens of Enterobacteriaceae. J Clin Microbiol (1975) 1.26
Adjunctive erythromycin treatment for idiopathic preterm labor: results of a randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol (1986) 1.26
Species and genotypic diversities and similarities of pathogenic yeasts colonizing women. J Clin Microbiol (1999) 1.26
Controlled clinical comparison of BacT/alert FA plus and FN plus blood culture media with BacT/alert FA and FN blood culture media. J Clin Microbiol (2013) 1.25
Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci. J Clin Microbiol (1995) 1.25
Neurocysticercosis in the United States: 35 cases and a review. Rev Infect Dis (1988) 1.24
Campylobacter enteritis in Denver. West J Med (1982) 1.23
Shigellosis in the United States: ten-year review of nationwide surveillance, 1964-1973. Am J Epidemiol (1976) 1.21
Significance of Clostridium tertium bacteremia in neutropenic and nonneutropenic patients: review of 32 cases. Clin Infect Dis (2001) 1.20
RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn Microbiol Infect Dis (1993) 1.20
The intercellular adhesin locus ica is present in clinical isolates of Staphylococcus aureus from bacteremic patients with infected and uninfected prosthetic joints. Med Microbiol Immunol (2001) 1.19
Application of rejection criteria for stool cultures for bacterial enteric pathogens. J Clin Microbiol (1993) 1.17